To include your compound in the COVID-19 Resource Center, submit it here.

Ironwood shareholders opt to keep board intact

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment officer at

Read the full 375 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE